4 - Inside ESG: Sustainable finance and the threat to divest

4 - Inside ESG: Sustainable finance and the threat to divest

If you want your investments to match your principles should a threat to divest be part of your long-term strategy?

In the fourth episode of our special five-part series on sustainable or ESG investing, produced in partnership with the FT’s Moral Money team, the story of the California State Teachers' Retirement System, or Calstrs, and why its decision to divest from the US private prisons industry prompted tears and passionate discussion on the board.


Joe Rennison, deputy US markets editor, assesses the long-term impact that divestment can have on companies, while Moral Money’s Patrick Temple-West, Attracta Mooney, the FT’s investment correspondent, and Lindsay Frost, a senior reporter at Agenda, an FT publication about the corporate board space, explain why divestment presents a conundrum for investors and whether passive investment funds are really compatible with ESG investing.


JPMorgan funds invested in CoreCivic debt after vow to stop financing private prisons

Bond funds wrestle with human rights dilemma

Divestment Concerns Creep In for More Industries


Check out stories and up-to-the-minute news from the Moral Money team here.


Get 30 days of the premium Moral Money newsletter free, together with complimentary access to FT.com for the same period, visit www.ft.com/insideesg


Review clips: Calstrs, NBC, Global News, PBS, AP, CBC News, The Guardian, CSPAN

Hosted on Acast. See acast.com/privacy for more information.

Episoder(319)

KKR, Bain and private equity’s push into Japan

KKR, Bain and private equity’s push into Japan

When international private equity groups first entered Japan at the turn of the 21st century, newspapers criticised them as vulture funds and politicians steered clear of public contact. Today, it’s a...

26 Nov 202521min

Coming soon from Tech Tonic: Defying death

Coming soon from Tech Tonic: Defying death

Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing...

24 Nov 20251min

What’s the deal with OpenAI's deals?

What’s the deal with OpenAI's deals?

OpenAI is entering a new era. It's restructured to add a for-profit arm to its business and has signed more than a trillion dollars’ worth of deals to secure chips and build out data centres. But thos...

19 Nov 202526min

Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multib...

12 Nov 202526min

The $17bn nuclear start-up without any revenue

The $17bn nuclear start-up without any revenue

Publicly-listed Oklo sits at the intersection of two hot areas for Wall Street: artificial intelligence and energy companies. This year alone, Oklo’s share price has jumped more than 400 per cent. But...

5 Nov 202523min

$12bn of debt: How First Brands Group collapsed

$12bn of debt: How First Brands Group collapsed

Some of the world’s biggest financial institutions are reeling after the collapse of a little-known car parts supplier: First Brands Group. The company filed for bankruptcy last month, and since then,...

29 Okt 202526min

Can the world’s largest listed hedge fund rebound?

Can the world’s largest listed hedge fund rebound?

The world’s largest listed hedge fund manager, Man Group, is at a crossroads. After years of high flying thanks to its innovative quant trading strategies, the company’s hedge fund unit has been falte...

22 Okt 202519min

Introducing Untold: Toxic Legacy

Introducing Untold: Toxic Legacy

Introducing Toxic Legacy, a new season of Untold from the Financial Times. Host Laura Hughes uncovers a lead poisoning epidemic across the UK. You might be living with lead and not know it: the toxin ...

16 Okt 20252min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
pengepodden-2
pengesnakk
tid-er-penger-en-podcast-med-peter-warren
finansredaksjonen
livet-pa-veien-med-jan-erik-larssen
utbytte
stormkast-med-valebrokk-stordalen
morgenkaffen-med-finansavisen
rss-sunn-okonomi
rss-markedspuls-2
lederpodden
liberal-halvtime
rss-pa-konto
rss-investering-gjort-enkelt